Phesi
Phesi provides comprehensive clinical development analytical products and services for biopharmaceutical companies around the world. Their integrated offerings cover the entire clinical development process—from development planning and indication assessment to protocol evaluation, site selection, and trial implementation management.
Content by Phesi
|3 min read
AI-Driven Trial Accelerator Platform Hits New Milestone with Data from 132 Million Patients
Latest version of Trial Accelerator™ incorporates new AI capabilities and product features to unlock a patient-centric approach to trial design and implementation
|3 min read
Breast Cancer Tops Most-Studied Diseases List for Fourth Year but Trial Attrition Rate Rises
A third of Phase 2 clinical trials were terminated in 2024, a 50 percent increase from before the pandemic
|2 min read
Type 2 Diabetes Now One of the Top Five Most Studied Diseases Globally, Finds New Analysis
Increase in T2D research comes at time of rising interest in GLP-1s, including Ozempic and Wegovy
|3 min read
Proof-of-Concept Study Uses AI-Based ‘Digital Twins’ to Replace Control Arms in Clinical Trials
Digital twin technology could address key challenges in clinical trial development, including reducing patient burdenPage 1 of 1
